(PharmaNewsWire.Com, April 21, 2017 ) Market Data Forecast published a syndicated report on the “Latin America Contraceptives Market” which estimates the market to reach USD 3.54 billion from USD 2.58 billion in 2016 with a high CAGR of 6.55%.
Contraception is the prevention of pregnancy by interfering with the process of implantation, ovulation and fertilization through the use of barriers, drugs, surgical techniques, medical devices. They are the drugs which will inhibit sexually transmitted diseases.
Various key factors which drive the market towards growth or restrain the market by downsizing the value are covered in the DROC analysis. Some of those key factors are advancement in technologies, growing development of effective female contraceptive drugs and devices, increasing initiatives from government and NGO to promote contraceptives. Side effects associated with the use of contraceptive drugs and devices, rising prevalence of infertility are the constraints that are hindering the growth of the market.
The products are segmented based on Drug Type and Medical Devices and studied for a deep-level understanding of the Contraceptives Market. Each sub segment is accompanied with Market Size Estimations and Y-o-Y Forecasts as well. Based on Drug type: • Contraceptive pills • Topical contraceptives • Contraceptive injectable • Others (contraceptive gels, jellies and creams) Based on Medical Devices: • Male contraceptive devices • Female contraceptive devices • Female condoms • Intrauterine devices • Contraceptive sponges • Contraceptive diaphragms • Contraceptive patches • Subdermal contraceptive implants • Non-surgical permanent contraceptive devices
The Latin America market is geographically segmented into Brazil, Mexico, Argentina, and rest of Latin America. Latin America contraceptives market is projected to grow at a swift rate owing to the presence of large economic development, untapped opportunities, rising patient awareness and constantly improving healthcare infrastructure.
As per the report, companies like Bayer HealthCare AG, Pace Pharmaceuticals Inc., Reckitt Benckiser plc, Medicines360, Merck & Co., Inc.,Church & Dwight, Co., Inc., Actavis, Inc., Mayer Laboratories, Inc., CooperSurgical, Inc., Medisafe Distribution Inc, Teva Pharmaceutical Industries Limited, and Pfizer, Inc.
Technological advancements in intrauterine contraceptive devices are anticipated to create new opportunities for new players in the global intrauterine contraceptive device market in the days to come. Raising number of mergers and acquisitions and increasing number of product innovations are some of the present-day trends noted in the global intrauterine contraceptive device market. Scope of the Latin America Contraceptives Market: • Regional and country-level analysis that provides an intrinsic perspective of Brazil, Argentina and Mexico markets to that of the Latin American region • Segment-level analysis on basis of Drug Type and Medical Devices along with market size forecasts and y-o-y estimations are provided for better understanding of major focus areas • Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics • Macro & Micro environmental factors such as political influence, legal barriers, technological prowess and industry rivalry are covered in the extensive PESTLE and Porter’s Five Forces Analyses. • Comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment • Mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies all rolled out into Competitive landscape • Expertly devised Market Outlook comprising the Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Medical Devices Segment:
About Market Data Forecast: Market Data Forecast is one of the prominent market research companies which offers syndicated as well as customized research services to individual or corporate clients. Their syndicated research reports contain Market Sizing and forecasts for 5-year period with a niche level of segmentation providing you with more focused insights whereas the consult research services can fetch the distinctive data requirements at competitive industry costs. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
